- South Korean biotech company secures US$8 million in upfront payment for the joint commercialization of the stem cell therapy CARTISTEM ® targeting the Japanese knee osteoarthritis market. SEOUL, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback